Rights and permissions
About this article
Cite this article
BMS + oral sirolimus more cost-effective than DES. Inpharma Wkly. 1604, 15 (2007). https://doi.org/10.2165/00128413-200716040-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716040-00026